120 related articles for article (PubMed ID: 37010930)
1. Tussilagone ameliorates high-fat diet-induced hepatic steatosis by enhancing energy metabolism and antioxidant activity.
Sun M; Li Y; Su S; Gao J; Yu L; Qi X; Liang H; Li X; Qi X; Liang Y; Zhou L; Zhang G; Li Y
Phytother Res; 2024 May; 38(5):2099-2113. PubMed ID: 37010930
[TBL] [Abstract][Full Text] [Related]
2. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
3. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
[TBL] [Abstract][Full Text] [Related]
4. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatic steatosis activity of Sicyos angulatus extract in high-fat diet-fed mice and chemical profiling study using UHPLC-qTOF-MS/MS spectrometry.
An JP; Choi JH; Huh J; Lee HJ; Han S; Noh JR; Kim YH; Lee CH; Oh WK
Phytomedicine; 2019 Oct; 63():152999. PubMed ID: 31280138
[TBL] [Abstract][Full Text] [Related]
6. Ginger Essential Oil Ameliorates Hepatic Injury and Lipid Accumulation in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
Lai YS; Lee WC; Lin YE; Ho CT; Lu KH; Lin SH; Panyod S; Chu YL; Sheen LY
J Agric Food Chem; 2016 Mar; 64(10):2062-71. PubMed ID: 26900108
[TBL] [Abstract][Full Text] [Related]
7. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
[TBL] [Abstract][Full Text] [Related]
8. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
[TBL] [Abstract][Full Text] [Related]
9. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
10. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
11. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis.
Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M
Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323
[TBL] [Abstract][Full Text] [Related]
12. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
13. Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota.
Liu HJ; Cao ST; Wen BY; Han X; Li Y; Li S; Li J; Zhang L
Int Immunopharmacol; 2021 Oct; 99():108065. PubMed ID: 34426119
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.
Li J; Xie S; Teng W
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010950
[TBL] [Abstract][Full Text] [Related]
15. Pistachio Consumption Prevents and Improves Lipid Dysmetabolism by Reducing the Lipid Metabolizing Gene Expression in Diet-Induced Obese Mice.
Terzo S; Caldara GF; Ferrantelli V; Puleio R; Cassata G; Mulè F; Amato A
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513740
[TBL] [Abstract][Full Text] [Related]
16. Food-drug interaction: Anabolic steroids aggravate hepatic lipotoxicity and nonalcoholic fatty liver disease induced by trans fatty acids.
Santos JDB; Mendonça AAS; Sousa RC; Silva TGS; Bigonha SM; Santos EC; Gonçalves RV; Novaes RD
Food Chem Toxicol; 2018 Jun; 116(Pt B):360-368. PubMed ID: 29704577
[TBL] [Abstract][Full Text] [Related]
17. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
Elife; 2023 Aug; 12():. PubMed ID: 37580962
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD.
Xie K; He X; Chen K; Sakao K; Hou DX
Food Funct; 2020 Jul; 11(7):5976-5991. PubMed ID: 32666969
[TBL] [Abstract][Full Text] [Related]
20. The combined impact of decabromodiphenyl ether and high fat exposure on non-alcoholic fatty liver disease in vivo and in vitro.
Chen S; Che S; Li S; Ruan Z
Toxicology; 2021 Dec; 464():153015. PubMed ID: 34757160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
